Analyst Ratings For Aduro Biotech (NASDAQ:ADRO)
Today, William Blair reiterated its Outperform rating on Aduro Biotech (NASDAQ:ADRO).
There are 8 buy ratings on the stock.
The current consensus rating on Aduro Biotech (NASDAQ:ADRO) is Buy (Score: 3.00) with a consensus target price of $20.00 per share, a potential 81.82% upside.
Some recent analyst ratings include
- 10/2/2017-William Blair Reiterated Rating of Outperform.
- 9/27/2017-HC Wainwright Reiterated Rating of Buy.
- 7/18/2017-Cowen and Company initiated coverage with a Outperform rating.
- 5/1/2017-Rodman & Renshaw initiated coverage with a Buy rating.
- 3/7/2017-FBR & Co Reiterated Rating of Buy.
- 3/7/2017-Roth Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For Aduro Biotech (NASDAQ:ADRO)
Aduro Biotech (NASDAQ:ADRO) has insider ownership of 6.60% and institutional ownership of 35.05%.
- On 9/18/2017 Blaine Templeman, VP, sold 2,884 with an average share price of $11.20 per share and the total transaction amounting to $32,300.80. View SEC Filing
- On 9/13/2017 Blaine Templeman, VP, sold 3,557 with an average share price of $10.99 per share and the total transaction amounting to $39,091.43. View SEC Filing
- On 9/13/2017 Elsas Andrea Van, Insider, sold 4,922 with an average share price of $10.99 per share and the total transaction amounting to $54,092.78. View SEC Filing
- On 9/13/2017 Gregory W Schafer, COO, sold 4,859 with an average share price of $10.99 per share and the total transaction amounting to $53,400.41. View SEC Filing
- On 9/1/2017 Dirk G Brockstedt, EVP, sold 10,000 with an average share price of $11.69 per share and the total transaction amounting to $116,900.00. View SEC Filing
- On 9/1/2017 Gregory W Schafer, COO, sold 20,000 with an average share price of $11.70 per share and the total transaction amounting to $234,000.00. View SEC Filing
- On 9/1/2017 Jennifer Lew, Insider, sold 6,600 with an average share price of $11.70 per share and the total transaction amounting to $77,220.00. View SEC Filing
Recent Trading Activity for Aduro Biotech (NASDAQ:ADRO)
Shares of Aduro Biotech closed the previous trading session at with shares trading hands.